|
|
|
|
|
enzyme inhibitors (D-glucose analogue), substrate reduction therapy |
|
|
|
|
|
estrogen agonists/antagonists |
|
|
|
estrogens, progestins |
|
farnesoid X receptor agonists |
|
|
|
epothilone B analogues |
|
erythropoiesis stimulating agents (ESA) |
|
estrogen receptor antagonists |
|
extended spectrum penicillins |
|
fatty acids |
|
|
|
|
|
|
|
|
|
|
|
flavanoids |
|
|
|
folate antagonists |
|
|
|
fusion inhibitors |
|
|
|
|
|
gamma aminobutyric acid gaba analogues, nonopioid analgesics |
|
glucose-dependent insulinotropic polypeptide (GIP) receptor agonists |
|
glutamate receptor antagonists |
